Disease Vectors Articles & Analysis
23 news found
As several gene therapy approvals for rare disease treatment gain steam in 2023, a comprehensive set of gene therapy development solutions is released to pave richer avenues for rare disease research. ...
For larger genes (>5Kb) the company has developed the innovative REVeRT vector platform. This platform uses an innovative vector approach to pack split genes into individual vgAAV vectors and generate a full-length protein via mRNA trans-splicing. ...
Moreover, they point to the great possibilities lentiviral-based gene therapies can offer for patients with devastating diseases,” said Gaurav Shah, M.D., Chief Executive Officer of Rocket Pharma. ...
In the prime dose, ‘ChAdOx1’ refers to the viral vector used in the vaccine to deliver the antigens. It is a virus which causes a common cold in chimpanzees, but it has been modified so that it can no longer cause disease. ChAdOx1 is the same viral vector used in the Oxford/AstraZeneca Covid-19 vaccine (which was co-invented by ...
Embers, Ph.D.,* associate professor of microbiology and immunology and director of vector-borne disease research at Tulane National Primate Research Center in Covington, Louisiana. Her research at Tulane focuses on the effectiveness of antibiotics and other therapeutics to eradicate Borrelia burgdorferi from the body while also exploring the many avenues related ...
Some of the newest vaccines for infectious diseases (such as viral vector vaccines and mRNA vaccines) are designed without the use of antigens. ...
ViGeneron GmbH, a gene therapy company, today announced a research collaboration to utilize its novel engineered adeno-associated virus (vgAAV) vectors with Daiichi Sankyo Company, Limited (“Daiichi Sankyo”), for delivering a novel therapeutic protein to address an undisclosed target in a highly prevalent ophthalmic disease. ...
(Nasdaq: BIIB, Cambridge, Mass., USA) to develop and commercialize gene therapy products based on adeno-associated virus (AAV) vectors to treat inherited eye diseases. The companies will use ViGeneron’s proprietary vgAAV, novel engineered AAV capsids, to efficiently transduce retinal cells via intravitreal injections. ...
ViGeneron’s innovative gene therapy pipeline addresses ophthalmic diseases with high unmet medical needs. Its lead product VG901 targets a disease gene for Retinitis pigmentosa (RP), for which there is currently no approved treatment option. ...
Since this list’s original publication in 2002, new vector-borne diseases have been identified and pests that had been previously thought of as benign or nuisance pests have been found to impact adversely public health. EPA, CDC, and USDA collaborated to update the list to incorporate significant changes regarding vector-borne ...
In the absence of hand-washing facilities, WHO officials warn that aid workers not only are at risk of contracting diseases, but may become vectors themselves. Water and Sanitation as Economic Issues Limited resources are often blamed for lack of sanitation and running water in many areas, but investment may have been slow because the problem has been framed ...
Purdue University environmental engineer Andrew Whelton explained: Stagnant Water in Plumbing While staying at home can help prevent COVID-19 transmission, stagnant water in water tanks, filters, heaters, and softeners can promote growth of the deadly Legionella bacterium that causes Legionnaires’ Disease, as well as other pathogenic bacteria. The researchers, however, ...
(Oxitec) to field test the use of genetically engineered Aedes aegypti mosquitoes as a way to reduce populations that serve as a vector for a variety of diseases including Zika virus. The EUP is designed to test the effectiveness of genetically engineered Aedes aegypti mosquitoes as a way to reduce mosquito populations in specific locations with monitoring and ...
CATEGORY “IDEAS/BUSINESS PROJECTS” Miramoon Pharma: New molecules aimed at treating diseases based on muscular dystrophy. Multiverse Computing: Quantum computing solutions and advanced artificial intelligence applied to finance and economics. Onena Medicines: Biotechnology company focused on the development of first-class medicines to treat patients with ...
Changes in temperature, humidity and rainfall influence vector-borne diseases such as malaria and dengue fever and water-borne diseases like diarrhea and cholera. ...
USPOULTRY and the USPOULTRY Foundation announce the completion of a funded research project at North Carolina State University in Raleigh, N.C., that evaluated a new vaccine to protect again two important diseases. The project is part of the Association’s comprehensive research program encompassing all phases of poultry and egg production and processing. ...
Results indicate that a greater number of mosquito species could increase competition for mosquitoes that spread malarial parasites, whilst more vertebrate species could increase the likelihood that malarial parasites end up in ‘dead-end hosts’ that are unable to transmit the disease any further. According to the World Health Organization, there is an urgent need for ...
The U.S. Centers for Disease Control and Prevention (CDC) estimates that in 2010, approximately 22,000 cases of Lyme disease were reported and another 8,000 more probable cases occurred nationwide. Early symptoms of Lyme disease are often similar to the flu. Borrelia burgdorferi is a species of Gram-negative bacteria and is also the cause of ...
''This data and this form of analysis should be used to improve modern modelling of environmental factors controlling vector borne disease," she said. Himanshu Thakkar, coordinator of the South Asia Network on Dams, Rivers and People, told SciDev.Net that the link between river basins and disease was known, but not studied in depth by ...
Under the convention DDT is allowed to be used in public health for disease vector control. These limited exemptions fall under an 'acceptable purposes' clause (EE 28/11/07), as recommended by and under the guidance of the World Health Organization (WHO). ...